2023 | Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial | Ren, Zhenggang; Ducreux, Michel; Abou-Alfa, Ghassan K; Merle, Philippe; Fang, Weijia; Edeline, Julien; Li, Zhiwei; Wu, Lihua; Assenat, Eric; Hu, Sheng; Rimassa, Lorenza; Zhang, Tao; Blanc, Jean-Frédéric; Pan, Hongming; Ross, Paul; Yen, Chia-Jui; Tran, Albert; Shao, Guoliang; Bouattour, Mohamed; Chen, Yajin; Meyer, Tim; Hou, Jinlin; Tougeron, David; Bai, Yuxian; Hou, Ming-Mo; Meng, Zhiqiang; Wu, John; Li, Vincent; Chica-Duque, Sandra; ANN-LII CHENG | Liver cancer | 10 | 10 | |
2021 | Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer | Hashimoto, Ayumi; Sarker, Debashis; Reebye, Vikash; Jarvis, Sheba; Sodergren, Mikael H; Kossenkov, Andrew; Sanseviero, Emilio; Raulf, Nina; Vasara, Jenni; Andrikakou, Pinelopi; Meyer, Tim; KAI-WEN HUANG ; ...etc. | Clinical cancer research : an official journal of the American Association for Cancer Research | 46 | 37 | |